Mpox Outbreak in Africa: 14,700 Cases Confirmed in 2024, WHO Warns of Rising Threat
The World Health Organization (WHO) has confirmed 14,700 cases of mpox across 20 African countries in 2024. Tragically, the outbreak of mpox claimed 66 lives. The WHO attributes the surge to multiple virus clades, especially the Clade Ib variant. This variant predominantly spreads in the Democratic Republic of Congo (DRC) and nearby nations.
Adding to the concern, imported cases of the Clade Ib variant have emerged outside Africa. These cases often involve travelers diagnosed after arriving in other countries.
Origins and Spread of the Clade Ib Variant
The Clade Ib variant was first identified in South Kivu, an eastern province of the DRC, around mid-September 2023. WHO reports highlight that the outbreak is worsened by limited surveillance capabilities and delayed reporting in many countries.
“Varying surveillance and restricted diagnostic access lead to underreporting and delayed detection,” warned the WHO. The organization has urged member states to bolster surveillance and reporting mechanisms to curb the spread.
Global and Continental Emergency Declarations
In mid-August 2024, the Africa Centers for Disease Control and Prevention declared mpox a public health emergency of continental security. Shortly after, the WHO elevated the disease to a public health emergency of international concern. This marked the second global alert for mpox in two years.
Mpox: A Rare but Serious Viral Disease
Mpox, also known as monkeypox, was first identified in laboratory monkeys in 1958. The viral disease spreads through body fluids, respiratory droplets, and contaminated materials. Symptoms include fever, rash, and swollen lymph nodes.
Though rare, the disease’s spread beyond Africa underscores its global threat. Imported cases reveal gaps in travel-related monitoring and early detection.
Challenges in Combating the Outbreak
Limited diagnostic capacity in countries like the DRC means many suspected cases go untested. “A significant number of suspected mpox cases never get confirmed,” stated the WHO.
These challenges have fueled calls for enhanced global support, resource allocation, and coordinated efforts to manage the outbreak effectively.
A Call for Action
As the new year begins, health experts stress the importance of sustained vigilance. Strengthened surveillance, increased diagnostic resources, and timely reporting are vital to containing the outbreak.
The WHO’s warnings should serve as a wake-up call for governments, health organizations, and global leaders to work together to combat this escalating public health crisis.
The World Health Organization (WHO) has confirmed 14,700 cases of mpox across 20 African countries in 2024. Tragically, the outbreak claimed 66 lives. The WHO attributes the surge to multiple virus clades, especially the Clade Ib variant. This variant predominantly spreads in the Democratic Republic of Congo (DRC) and nearby nations.
Adding to the concern, imported cases of the Clade Ib variant have emerged outside Africa. These cases often involve travelers diagnosed after arriving in other countries.
Origins and Spread of the Clade Ib Variant
The Clade Ib variant was first identified in South Kivu, an eastern province of the DRC, around mid-September 2023. WHO reports highlight that the outbreak is worsened by limited surveillance capabilities and delayed reporting in many countries.
“Varying surveillance and restricted diagnostic access lead to underreporting and delayed detection,” warned the WHO. The organization has urged member states to bolster surveillance and reporting mechanisms to curb the spread.
Global and Continental Emergency Declarations
In mid-August 2024, the Africa Centers for Disease Control and Prevention declared mpox a public health emergency of continental security. Shortly after, the WHO elevated the disease to a public health emergency of international concern. This marked the second global alert for mpox in two years.
Mpox: A Rare but Serious Viral Disease
Mpox, also known as monkeypox, was first identified in laboratory monkeys in 1958. The viral disease spreads through body fluids, respiratory droplets, and contaminated materials. Symptoms include fever, rash, and swollen lymph nodes.
Though rare, the disease’s spread beyond Africa underscores its global threat. Imported cases reveal gaps in travel-related monitoring and early detection.
Challenges in Combating the Outbreak
Limited diagnostic capacity in countries like the DRC means many suspected cases go untested. “A significant number of suspected mpox cases never get confirmed,” stated the WHO.
These challenges have fueled calls for enhanced global support, resource allocation, and coordinated efforts to manage the outbreak effectively.
A Call for Action
As the new year begins, health experts stress the importance of sustained vigilance. Strengthened surveillance, increased diagnostic resources, and timely reporting are vital to containing the outbreak.
The WHO’s warnings should serve as a wake-up call for governments, health organizations, and global leaders to work together to combat this escalating public health crisis.
The World Health Organization (WHO) has confirmed 14,700 cases of mpox across 20 African countries in 2024. Tragically, the outbreak claimed 66 lives. The WHO attributes the surge to multiple virus clades, especially the Clade Ib variant. This variant predominantly spreads in the Democratic Republic of Congo (DRC) and nearby nations.
Adding to the concern, imported cases of the Clade Ib variant have emerged outside Africa. These cases often involve travelers diagnosed after arriving in other countries.
Origins and Spread of the Clade Ib Variant
The Clade Ib variant was first identified in South Kivu, an eastern province of the DRC, around mid-September 2023. WHO reports highlight that the outbreak is worsened by limited surveillance capabilities and delayed reporting in many countries.
“Varying surveillance and restricted diagnostic access lead to underreporting and delayed detection,” warned the WHO. The organization has urged member states to bolster surveillance and reporting mechanisms to curb the spread.
Global and Continental Emergency Declarations
In mid-August 2024, the Africa Centers for Disease Control and Prevention declared mpox a public health emergency of continental security. Shortly after, the WHO elevated the disease to a public health emergency of international concern. This marked the second global alert for mpox in two years.
Mpox: A Rare but Serious Viral Disease
Mpox, also known as monkeypox, was first identified in laboratory monkeys in 1958. The viral disease spreads through body fluids, respiratory droplets, and contaminated materials. Symptoms include fever, rash, and swollen lymph nodes.
Though rare, the disease’s spread beyond Africa underscores its global threat. Imported cases reveal gaps in travel-related monitoring and early detection.
Challenges in Combating the Outbreak
Limited diagnostic capacity in countries like the DRC means many suspected cases go untested. “A significant number of suspected mpox cases never get confirmed,” stated the WHO.
These challenges have fueled calls for enhanced global support, resource allocation, and coordinated efforts to manage the outbreak effectively.
A Call for Action
As the new year begins, health experts stress the importance of sustained vigilance. Strengthened surveillance, increased diagnostic resources, and timely reporting are vital to containing the outbreak.
The WHO’s warnings should serve as a wake-up call for governments, health organizations, and global leaders to work together to combat this escalating public health crisis.
ALSO READ:Tragedy Strikes in Embu: Three Die as Probox Crashes Into Garage and Bursts Into Flames
Mpox Outbreak in Africa: 14,700 Cases Confirmed in 2024, WHO Warns of Rising Threat
